Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors

Journal of Biological ChemistryJournal of Biological ChemistryVolume 298, Issue 10, October 2022, 102423Journal home page for Journal of Biological Chemistry

Gamma-aminobutyric acid type A (GABAA) receptors are the primary inhibitory neurotransmitter-gated ion channels in the mammalian central nervous system. Maintenance of GABAA receptor protein homeostasis (proteostasis) in cells utilizing its interacting proteins is essential for the function of GABAA receptors. However, how the proteostasis network orchestrates GABAA receptor biogenesis in the endoplasmic reticulum is not well understood. Here, we employed a proteomics-based approach to systematically identify the interactomes of GABAA receptors. We carried out a quantitative immunoprecipitation-tandem mass spectrometry analysis utilizing stable isotope labeling by amino acids in cell culture. Furthermore, we performed comparative proteomics by using both WT α1 subunit and a misfolding-prone α1 subunit carrying the A322D variant as the bait proteins. We identified 125 interactors for WT α1-containing receptors, 105 proteins for α1(A322D)-containing receptors, and 54 overlapping proteins within these two interactomes. Our bioinformatics analysis identified potential GABAA receptor proteostasis network components, including chaperones, folding enzymes, trafficking factors, and degradation factors, and we assembled a model of their potential involvement in the cellular folding, degradation, and trafficking pathways for GABAA receptors. In addition, we verified endogenous interactions between α1 subunits and selected interactors by using coimmunoprecipitation in mouse brain homogenates. Moreover, we showed that TRIM21 (tripartite motif containing-21), an E3 ubiquitin ligase, positively regulated the degradation of misfolding-prone α1(A322D) subunits selectively. This study paves the way for understanding the molecular mechanisms as well as fine-tuning of GABAA receptor proteostasis to ameliorate related neurological diseases such as epilepsy.

Keywords

GABAA receptor

epilepsy

SILAC

interactome

proteostasis

folding

assembly

trafficking

degradation

AbbreviationsDAVID

Database for Annotation, Visualization and Integrated Discovery

DMEM

Dulbecco’s modified Eagle's medium

ERAD

ER-associated degradation

GABAA

gamma-aminobutyric acid type A

HEK293T

human embryonic kidney 293T cell line

IP–MS/MS

immunoprecipitation–tandem mass spectrometry

SILAC

stable isotope labeling by amino acids in cell culture

SRP

signal recognition particle

TRIM21

tripartite motif containing-21

UGGT1

UDP-glucose glycoprotein glucosyltransferase 1

© 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.

留言 (0)

沒有登入
gif